Regulatory Scientific and Health Solutions is now offering a 1-day face-to-face course about health economics models for assessing cancer drugs. Attendees will learn how the models are made and applied, along with how their results are interpreted and acted upon by payer and health technology assessment (HTA) agencies. The course takes place on Monday 3rd October 2022 at the Hilton London Watford in Watford, UK. Registration ends 1st August 2022.
By the end of the course, according to RSS, learners should be able to,
- “Understand cancer outcomes important for health economics and reimbursement.
- Understand what reimbursement agencies are asking for.
- Interpret analyses and results from health economic models in cancer for key decisions.
- Prepare for regulatory filing, including Promising Innovative Medicinal Status (PIMS) and Early Access to Medicines Schemes (EAMS) to leverage for early reimbursement.
- Understand factors predictive of HTA success for global markets.”
Click here to register today.
(Source: RSS, June 22nd, 2022)
